The place of tramadol in the therapy of pain (Concluding remarks)

Drugs

Volumn 53, Issue SUPPL. 2, 1997, Pages 65-66

  Besson, J M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; TRAMADOL;

ANALGESIC ACTIVITY; CANCER PAIN; CHRONIC PAIN; CONFERENCE PAPER; HUMAN; POSTHERPETIC NEURALGIA;

EID: 0030985701     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199700532-00012     Document Type: Conference Paper

References (15)

1. 1. S Rashad P Revell A Hemingway 1989 Effect of non-steroidal anti-inflamatory drugs on the course of osteoarthritis Lancet 2 519 22 2570233 10.1016/S0140-6736(89)90651-X 1:STN:280:DyaL1MzmtlOgtQ%3D%3D Rashad S, Revell P, Hemingway A, et al. Effect of non-steroidal anti-inflamatory drugs on the course of osteoarthritis. Lancet 1989; 2: 519–22
2. 2. M Zenz A Willweber-Strumpf 1993 Opiophobia and cancer pain in Europe Lancet 341 1075 76 8096970 10.1016/0140-6736(93)92425-S 1:STN:280:DyaK3s3isFOhsQ%3D%3D Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993; 341: 1075–76
3. 3. R Dubner MB Max 1992 Antidepressants and the relief of neuropathic pain: evidence for noradrenergic mechanisms J-M Besson G Guilbaud Towards the use of noradrenergic agonists for the treatment of pain 211 8 Dubner R, Max MB. Antidepressants and the relief of neuropathic pain: evidence for noradrenergic mechanisms. In: Besson J-M, Guilbaud G, editors. Towards the use of noradrenergic agonists for the treatment of pain. 1992: 211–8
4. 4. V Kayser J-M Besson G Guilbaud 1992 Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat Eur J Pharmacol 224 83 8 1360407 10.1016/0014-2999(92)94822-D 1:CAS:528:DyaK3sXjt1ykuw%3D%3D Kayser V, Besson J-M, Guilbaud G. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur J Pharmacol 1992; 224: 83–8
5. 5. RB Raffa E Friderichs W Reimann 1992 Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic J Pharmacol Exp Ther 260 275 85 1309873 1:CAS:528:DyaK38Xht1Sktrs%3D Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275–85
6. 6. P Dayer 1994 The pharmacology of tramadol Drugs 47 Suppl.1 3 7 7517823 10.2165/00003495-199400471-00003 1:CAS:528:DyaK2cXmt1Skt7o%3D Dayer P. The pharmacology of tramadol. Drugs 1994; 47 Suppl. 1: 3–7
7. 7. MD Vickers D O’Flaherty SM Szekely 1992 Tramadol: pain relief by an opioid without depression of respiration Anaesthesia 47 291 6 1519677 10.1111/j.1365-2044.1992.tb02166.x 1:CAS:528:DyaK38XisVyhu70%3D Vickers MD, O’Flaherty D, Szekely SM, et al. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992; 47: 291–6
8. 8. W Keup 1993 Missbrauchsmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976–1990 Lambertus Verlag Freiburg im Breisgau, Allemagne 48 145 Keup W. Missbrauchsmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976–1990; Freiburg im Breisgau, Allemagne: Lambertus Verlag, 1993: 48–145
9. 9. L Collart C Luthy P Dayer 1993 Partial inhibition of tramadol antinociceptive effect by naloxone in man. Proceedings of the British Pharmacological Society; 1992 Sep: London Br J Clin Pharmacol 35 73 Collart L, Luthy C, Dayer P. Partial inhibition of tramadol antinociceptive effect by naloxone in man. Proceedings of the British Pharmacological Society; 1992 Sep: London. Br J Clin Pharmacol 1993; 35: 73
10. 10. J Desmeules V Piguet L Collart 1994 Contribution of mono-aminergic modulation in tramadol analgesic effect Clin Pharmacol Ther 55 2 151 [Abstract] Desmeules J, Piguet V, Collart L, et al. Contribution of mono-aminergic modulation in tramadol analgesic effect [Abstract]. Clin Pharmacol Ther 1994; 55(2): 151
11. 11. RB Raffa E Friderichs G Reimann 1993 Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol J Pharmacol Exp Ther 267 1 331 40 8229760 1:CAS:528:DyaK2cXitlSqtQ%3D%3D Raffa RB, Friderichs E, Reimann G, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267(1): 331–40
12. 12. KA Lehmann 1994 Tramadol for the management of acute pain Drugs 47 Suppl.1 19 32 7517822 10.2165/00003495-199400471-00005 Lehmann KA. Tramadol for the management of acute pain. Drugs 1994; 47 Suppl. 1: 19–32
13. 13. H Göbel TH Stadler 1997 Traitement des douleurs post-zostériennes par le tramadol: résultats d’une étude pilote ouverte versus clomipramine avec ou sans lévomépromazine Drugs 53 Suppl.2 34 9 9190323 10.2165/00003495-199700532-00008 Göbel H, Stadler TH. Traitement des douleurs post-zostériennes par le tramadol: résultats d’une étude pilote ouverte versus clomipramine avec ou sans lévomépromazine. Drugs 1997; 53 Suppl. 2: 34–9
14. 14. AV Bono S Cuffari 1997 Efficacité et tolérance du tramadol dans les douleurs néoplasiques: étude comparative par rapport à la buprénorphine Drugs 53 Suppl.2 40 49 9190324 10.2165/00003495-199700532-00009 Bono AV, Cuffari S. Efficacité et tolérance du tramadol dans les douleurs néoplasiques: étude comparative par rapport à la buprénorphine. Drugs 1997; 53 Suppl. 2: 40–49
15. 15. M Cossmann C Kohnen R Langford 1997 Tolérance et sécurité d’emploi du tramadol: résultats des études internationales et données de la pharmacovigilance Drugs 53 Suppl.2 50 62 9190325 10.2165/00003495-199700532-00010 Cossmann M, Kohnen C, Langford R, et al. Tolérance et sécurité d’emploi du tramadol: résultats des études internationales et données de la pharmacovigilance. Drugs 1997; 53 Suppl. 2: 50–62